A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease von Vichinsky, Elliott, Hoppe, Carolyn C, Ataga, Kenneth I, Ware, Russell E, Nduba, Videlis, El-Beshlawy, Amal, Hassab, Hoda, Achebe, Maureen M, Alkindi, Salam, Brown, R. Clark, Diuguid, David L, Telfer, Paul, Tsitsikas, Dimitris A, Elghandour, Ashraf, Gordeuk, Victor R, Kanter, Julie, Abboud, Miguel R, Lehrer-Graiwer, Joshua, Tonda, Margaret, Intondi, Allison, Tong, Barbara, Howard, Jo

Volltext

Pharmacokinetics of Diphenhydramine and a Demethylated Metabolite Following Intravenous And Oral Administration von Blyden, Gershwin T., Greenblatt, David J., Scavone, Joseph M., Shader, Richard I.

Volltext

Effect of cyclosporin A on rat kidney catecholamines von Duruibe, Valentine A., Okonmah, Anthony, Panton, Lloyd, Blyden, Gershwin T.

Volltext

Metronidazole Impairs Clearance of Phenytoin but Not of Alprazolam or Lorazepam von Blyden, Gershwin T., Scavone, Joseph M., Greenblatt, David J.

Volltext

Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam von SCAVONE, J. M, BLYDEN, G. T, GREENBLATT, D. J

Volltext

Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines von Lachman, Lawrence B., Hacker, Miles P., Blyden, Gershwin T., Handschumacher, Robert E.

Volltext

Antipyrine Pharmacokinetics in Women Receiving Conjugated Estrogens von Scavone, Joseph M., Greenblatt, David J., Blyden, Gershwin T.

Volltext

Validity of a two-point acetaminophen pharmacokinetic study von SCAVONE, J. M, GREENBLATT, D. J, BLYDEN, G. T, LUNA, B. G, HARMATZ, J. S

Volltext

Cyclosporine Blood Concentrations Determined by Specific Versus Nonspecific Assay Methods von Blyden, Gershwin T., Franklin, Cass, Cho, Sang I., Kaplan, Marshall M., Hirsch, Carl A., Greenblatt, David J.

Volltext

Characterization of lymphocyte activating factor from mouse tumor cell lines and human leukocytes von Lachman, Lawrence B., Blyden, Gershwin T., Hacker, Miles, Handschumacher, Robert E.

Volltext

Case series of patients with severe sickle cell disease treated with voxelotor (GBT440) by compassionate access von Blyden, Gershwin, Bridges, Kenneth R., Bronte, Lanetta

Volltext

A Single Center Experience of GBT440 Treatment of Severe Anemia in Sickle Cell Disease (SCD) von Bridges, Kenneth R., Gershwin, Blyden, Bronte, Lanetta

Volltext

Assessment of Biomarker Response to Clinical Administration of Adakveo in a “Real World” Clinical Setting: A Model for Therapeutic Monitoring in Sickle Cell Disease (SCD) von White, Jennell, Packer-Pencle, Corrine, Gao, Xiufeng, Williams-Montgomery, Andrekia, Blyden, Gershwin Theophilus, Bronté-Hall, Lanetta, Hines, Patrick C.

Volltext

Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling... von Kuo, Kevin H.M., Singer, Sylvia Titi, Blyden, Gershwin Theophilus, Bronté-Hall, Lanetta, Faller, Aidan, Kutlar, Abdullah, Kuypers, Frans A., Zaidi, Aliya U., Hines, Patrick C., Patel, Niren, Larkin, Sandra, Al-Samkari, Hanny, Sheth, Sujit, Nouraie, Seyed Mehdi, Perrine, Susan

Volltext

Treatment with IMR-687, a Highly Selective PDE9 Inhibitor, Increases HbF and Reduces VOCs in Adults with Sickle Cell Disease in a Long-Term, Phase 2a, Open-Label Extension Study von Andemariam, Biree, Mant, Timothy, Eleftheriou, Perla, Lugthart, Sanne, Bronté-Hall, Lanetta, Barroso, Filipa, Blyden, Gershwin, Mason, James, Barysauskas, Constance M, Yen, Joseph, Tang, Karen, Ballal, Rahul, Attie, Kenneth

Volltext

Benefits and Safety of Long-Term Use of IMR-687 As Monotherapy or in Combination with a Stable Dose of Hydroxyurea (HU) in 2 Adult Sickle Cell Patients von Bronte-Hall, Lanetta, Andemariam, Biree, Gershwin, Blyden, Lugthart, Sanne, Mant, Timothy, Howard, Jo, Fok, Henry, Eleftheriou, Perla, Hagar, Robert Ward, Mason, James, Ballal, Rahul, Lufkin, Joelle, Lisbon, Eleanor

Volltext

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism von Idowu, Modupe, DeBaun, Michael R., Burnett, Arthur, Darbari, Deepika S., Adam, Soheir, Anderson, Alan Randall, Kanter, Julie, Billett, Henny H., Liles, Darla K., Nickel, Robert S., Decastro, Laura M., Andemariam, Biree, Blyden, Gershwin Theophilus, Heeney, Matthew M., Ramadas, Poornima, McLemore, Morgan L., Kolekar, Yogita, Laine, Dramane, Paulose, Jincy, Sarkar, Rajendra, Vignogna, Mary Beth, El Rassi, Fuad

Volltext

Real-World Clinical Burden of Sickle Cell Disease in the US Community-Practice Setting: A Single-Center Experience from the Foundation for Sickle Cell Disease Research von Bronté-Hall, Lanetta, Parkin, Matthew, Green, Courtney, Tchouambou, Elsa, Huynh, Lynn, Puri-Sharma, Charu, Chang, Rose, Chawla, Anjulika, Signorovitch, James, Blyden, Gershwin Theophilus

Volltext

The Benefits Trial of PB-04 to Evaluate Safety, PK, and Preliminary Efficacy in Inducing Fetal Globin Expression in Beta Thalassemia Intermedia and Sickle Cell Disease von Kuo, Kevin H.M., Singer, Sylvia, Sheth, Sujit, Al-Samkari, Hanny, Blyden, Gershwin, Bronte-Hall, Lanetta, Pace, Betty S., Kutlar, Abdullah, Kuypers, Franciscus A., Faller, Aidan D, Nouraie, Seyed Mehdi, Terse, Pramod, Jin, Haksong, Xu, Xin, Alimardanov, Asaf, Sytkowski, Arthur J., Haugabook, Sharie, Perrine, Susan P

Volltext

Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells von Green, D F, Duruibe, V A, Blyden, G, Laskey, R E, Bourgoignie, J J

Volltext